课题基金 / 基金详情

Tracking a revolution: Evaluating the impact of modern HCV therapy on HIV-HCV coinfection

Tracking a revolution: Evaluating the impact of modern HCV therapy on HIV-HCV coinfection
追踪革命：评估现代 HCV 疗法对 HIV-HCV 合并感染的影响
批准号：
313381
负责人：
Klein Marina B
金额：
$352.24万
依托单位：
Research Institute of the McGill University Health Centre
依托单位国家：
加拿大
项目类别：
Operating Grants
财政年份：
2014
资助国家：
加拿大
项目状态：
已结题
起止时间：
2014-09-01 至 2021-09-01
来源：
https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=313381&lang=en
关键词：
Antiviral Treatments Clinical Trials Cohort Study Health Economics Health Outcomes Hepatitis C Virus (Hcv) Hiv Methods Models Of Care Vulnerable Populations

项目摘要

项目成果

Klein Marina B的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
<html> <body> <p> <strong>RESEARCH PROGRAM</strong> </p> <p>New, highly effective therapies that directly target HCV (DAAs) will completely alter the landscape for HCV infected patients. But we are faced with a fundamental paradox. DAAs are the most
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
26th International Workshop on HIV and Hepatitis Observational Databases (IWHOD)
After the Cure: Measuring the full impacts of direct-acting antivirals for people living with HIV/hepatitis C virus coinfection in Canada
After the Cure: Measuring the full impacts of direct acting antivirals for people living with HIV/hepatitis C virus coinfection in Canada
5th International HIV/Viral Hepatitis Co-infection IAS Satellite Meeting
海外基金